HIGHLIGHTS
- who: Report et al. from the USA USA USA have published the paper: Review began 11/17/2022 Review ended 01/18/2023 Published 01/30/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/30,/2023
- what: 2023 Mustafa et_al Cureus 15(1): e34414.
SUMMARY
Fabry`s disease (FD) is a deficiency of the alpha-galactosidase enzyme leading to a buildup of globotriaosylceramide (Gb3). The classic findings for FD patients may present with severe neuropathic pain, telangiectasias/angiokeratomas, corneal opacities, and renal dysfunction. Learning objectives: To better understand the Fabry . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.